SB 308
Alternative Names: SB-308Latest Information Update: 08 Mar 2024
At a glance
- Originator SanBio
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Muscular dystrophies
Most Recent Events
- 26 Feb 2024 Early research in Muscular dystrophies in USA (Parenteral) (SanBio Pipeline, February 2024)